News and Announcements

State of the University 2013

“A new initiative I am particularly pleased to announce today is the forthcoming launch of the Georgia State Institute for Biomedical Sciences. This institute evolves from that part of the strategic plan that recommended enhanced contributions to the sciences, health and medical education.
– President Mark Becker
October 2013

A Vaccine With Virus-Like Nanoparticles Is An Effective Treatment For RSV, Study Finds

ATLANTA—A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University. Their findings, published on July 14 in the International Journal of Nanomedicine, suggest this vaccine induces long-term protection against RSV and could be a novel treatment option for this disease. There is no licensed RSV vaccine.